Single Nucleotide-Catalyzed Biomimetic Reductive Amination
作者:Atul Kumar、Siddharth Sharma、Ram Awatar Maurya
DOI:10.1002/adsc.201000178
日期:2010.9.10
successfully developed a single nucleotide (adenosine 5′‐diphosphate)‐catalyzed enantioselective direct reductiveamination of aldehydes and ketones using a Hantzsch ester as reducing agent. The process is a simple, efficient and a real mimic of the NADH reduction approach for the synthesis of structurally diverse amines. This reaction is the first report demonstrating the ability of a single nucleotide as catalyst
作者:R. Ian Storer、Diane E. Carrera、Yike Ni、David W. C. MacMillan
DOI:10.1021/ja057222n
日期:2006.1.1
The first enantioselectiveorganocatalyticreductive amination reaction has been accomplished. The development of a new chiral phosphoric acid catalyst has provided a convenient strategy for the enantioselective construction of protected primary amines and provided a highly stereoselective method for the reductive amination of heterocyclic amines. A diverse spectrum of ketone and amine substrates can
The catalytic transfer hydrogenation of imines and the reductive amination of carbonyl compounds have been thoroughly investigated with a cyclooctene‐derived (cyclopentadienone)iron pre‐catalyst. Additionally, enantioselective ketimine reduction with a chiral (cyclopentadienone)ironcomplex is reported here for the first time.
The chiral phosphoric acid catalyzed enantioselective transferhydrogenation of various ketimines was achieved by the use of 2-aryl indoline as the hydrogen donor. Corresponding chiral amines were obtained in good chemical yields with excellent enantioselectivities.
Rationally-Designed<i>S-</i>Chiral Bissulfinamides as Highly Enantioselective Organocatalysts for Reduction of Ketimines
作者:Dong Pei、Yu Zhang、Siyu Wei、Meng Wang、Jian Sun
DOI:10.1002/adsc.200700504
日期:2008.3.7
example of S-chiral organocatalysts, that are highly efficient and enantioselective in substoichometric amounts, and which use a chiral monosulfinamide group as Lewis base to activate trichlorosilane (HSiCl3) to reduce N-arylketimines. A plausible mechanism involving two molecules of the monosulfinamde catalyst for the activation of HSiCl3 prompted us to design S-chiral bissulfinamides as new catalysts